Publications and presentations


Early initiation of combination antiretroviral therapy in HIV-1-infected newborns can achieve sustained virologic suppression with low frequency of CD4+ T cells carrying HIV in peripheral blood.  Bitnun A, Samson L, Chun TW, Kakkar F, Brophy J, Murray D, Justement S, Soudeyns H, Ostrowski M, Mujib S, Harrigan PR, Kim J, Sandstrom P, Read SE. Clin Infect Dis. (2014) 59 (7): 1012-1019.


Low but detectable IFN-γ responses against clade-matched HIV-1 peptides in early-treated vertically-infected children with long-term sustained viral suppression. Dieumegard H, Salem Fourati I, Le Campion A, Kakkar F, Brophy J, Samson L, Hawkes M, Read S, Bitnun A, Soudeyns H and the EPIC4 Study Group. Poster presentation, IAS Conference 2015, Vancouver, Canada.

Impact of early initiation of combination antiretroviral therapy on measures of virus in peripheral blood of vertically HIV-1-infected children. IAS Conference 2014, Melbourne, Australia.